Dr. Gandhi'S Laboratory Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 04-07-2024
- Paid Up Capital ₹ 3.18 Cr
as on 04-07-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.73 Cr
as on 04-07-2024
- Satisfied Charges ₹ 1.40 Cr
as on 04-07-2024
- Revenue -36.24%
(FY 2018)
- Profit -34.63%
(FY 2018)
- Ebitda -20.10%
(FY 2018)
- Net Worth 4.28%
(FY 2018)
- Total Assets 6.19%
(FY 2018)
About Dr. Gandhi'S Laboratory
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.18 Cr.
The company currently has active open charges totaling ₹2.73 Cr. The company has closed loans amounting to ₹1.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Apolo Das, Chetan Gandhi, Raju Mondal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233WB2014PTC199780
- Company No.
199780
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2014
- Date of AGM
28 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
North 24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. Gandhi'S Laboratory?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debangshu Das  | Additional Director | Current | |
| Apolo Das | Additional Director | Current | |
| Chetan Gandhi | Director | 27-Jan-2014 | Current |
| Raju Mondal | Director | 24-Sep-2022 | Current |
Financial Performance of Dr. Gandhi'S Laboratory.
Dr. Gandhi'S Laboratory Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 36.24% decrease. The company also saw a substantial fall in profitability, with a 34.63% decrease in profit. The company's net worth moved up by a moderate rise of 4.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Gandhi'S Laboratory?
In 2018, Dr. Gandhi'S Laboratory had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gold Magenta Hospitality Products & Services Private LimitedActive 17 years 9 monthsApolo Das and Debangshu Das are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 23 Jul 2018 | ₹2.73 Cr | Open |
Idbi Bank Limited Creation Date: 30 Mar 2015 | ₹1.40 Cr | Satisfied |
How Many Employees Work at Dr. Gandhi'S Laboratory?
Dr. Gandhi'S Laboratory has a workforce of 13 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Gandhi'S Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Gandhi'S Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
